Author:
Viganò Anna,De Felice Francesca,Iacovelli Nicola Alessandro,Alterio Daniela,Ingargiola Rossana,Casbarra Alessia,Facchinetti Nadia,Oneta Olga,Bacigalupo Almalina,Tornari Elena,Ursino Stefano,Paiar Fabiola,Caspiani Orietta,Di Rito Alessia,Musio Daniela,Bossi Paolo,Steca Patrizia,Jereczek-Fossa Barbara Alicja,Caso Letizia,Palena Nicola,Greco Andrea,Orlandi Ester
Abstract
Abstract
Purpose
The present study examined the longitudinal trajectories, through hierarchical modeling, of quality of life among patients with head and neck cancer, specifically symptoms burden, during radiotherapy, and in the follow-up period (1, 3, 6, and 12 months after completion of radiotherapy), through the M.D. Anderson Symptom Inventory Head and Neck questionnaire, formed by three factors. Furthermore, analyses were conducted controlling for socio-demographic as well as clinical characteristics.
Methods
Multi-level mixed-effects linear regression was used to estimate the association between quality of life and time, age, gender, household, educational level, employment status, ECOG performance status, human papilloma virus (HPV) status, surgery, chemotherapy, alcohol intake, and smoking.
Results
Among the 166 participants, time resulted to be a predictor of all the three questionnaire factors, namely, general and specific related symptoms and interference with daily life. Moreover, regarding symptom interference with daily activities factor, HPV-positive status played a significant role. Considering only HPV-negative patients, only time predicted patients’ quality of life. Differently, among HPV-positive patients, other variables, such as gender, educational level, alcohol use, surgery, age at diagnosis, employment status, and ECOG status, resulted significant.
Conclusion
It was evident that quality of life of patients with head and neck cancer declined during RT, whereas it slowly improved after ending treatment. Our results clarified the role of some socio-demographic and clinical variables, for instance, HPV, which would allow to develop treatments tailored to each patient.
Funder
Università degli Studi di Roma La Sapienza
Publisher
Springer Science and Business Media LLC